Pyrogallol, Corilagin and Chebulagic acid target the "fuzzy coat" of alpha-synuclein to inhibit the fibrillization of the protein

• Published in: RSC advances Vol. 12; no. 55; pp. 3577 - 35777
• Main Authors: Bopardikar, Mandar, Koti Ainavarapu, Sri Rama, Hosur, Ramakrishna V
• Format: Journal Article
• Language: English
• Published: England Royal Society of Chemistry 12-12-2022; The Royal Society of Chemistry
• Subjects: Atrophy; Catechol; Central nervous system; Chemistry; NMR; Nuclear magnetic resonance; Parkinson's disease; Proteins
• ISSN: 2046-2069; 2046-2069
• DOI: 10.1039/d2ra04358k

The accumulation of the intrinsically disordered protein alpha-synuclein (αSyn) in the form of insoluble fibrillar aggregates in the central nervous system is linked to a variety of neurodegenerative disorders such as Parkinson's disease, Lewy body dementia, and multiple system atrophy. Here we show that Pyrogallol, Corilagin and Chebulagic acid, compounds containing a different number of catechol rings, are independently capable of delaying and reducing the extent of αSyn fibrillization. The efficiency of inhibition was found to correlate with the number of catechol rings. Further, our NMR studies reveal that these compounds interact with the N-terminal region of αSyn which is unstructured even in the fibrillar form of the protein and is known as the "fuzzy coat" of fibrils. Thus, Corilagin and Chebulagic acid target the fuzzy coat of αSyn and not the amyloid core which is a common target for the inhibition of protein fibrillization. Our results indicate that the N-terminus also plays a key role in the fibrillization of αSyn.
Catechol-based small molecules (Pyrogallol, Corilagin and Chebulagic acid) inhibit alpha-synuclein fribillization by interactions through the protein N-terminus.